| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| R&D Expense | $175.0M | +38.3% |
| SG&A Expense | $59.8M | +18.3% |
| Operating Income | -$234.8M | -32.6% |
| Interest Expense | $4.5M | +129.1% |
| Pre-tax Income | -$215.4M | -23.8% |
| Income Tax | $408K | +41.7% |
| Net Income | -$215.8M | -23.8% |
| EPS (Basic) | -$3.24 | -8.4% |
| EPS (Diluted) | -$3.24 |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $74.5M | -49.2% |
| Short-term Investments | $346.2M | -20.7% |
| Current Assets | $433.7M | -26.8% |
| Total Assets | $487.7M | -24.6% |
| Current Liabilities | $40.4M | +19.6% |
| Long-term Debt | $44.8M | +56.4% |
| Total Liabilities | $113.2M | +24.0% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$185.5M | -44.8% |
| Investing Cash Flow | $97.2M | +168.2% |
| Financing Cash Flow | $16.3M | -94.8% |
| -8.4% |
| Stockholders' Equity |
| $374.5M |
| -32.6% |